Altered cyclin D1 genotype distribution in human sporadic pituitary adenomas

Medical Science Monitor

Volumn 13, Issue 10, 2007, Pages

  Gazioglu, Nurperi ^a,c   Erensoy, Nevin ^b   Kadioglu, Pinar ^a   Sayitoglu, Muge Aydin ^b   Ersoy, Ismail Hakki ^a   Hatirnaz, Ozden ^b   Kisacik, Bunyamin ^a   Oz, Buge ^a   Sar, Mehmet ^a   Ozbek, Ugur ^b   Ciplak, Nejat ^a   Cagatay, Penbe ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Cyclin D1; Immunohistochemistry; Pituitary adenoma; Polymorphism

Indexed keywords

CYCLIN D1;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER INVASION; CANCER TISSUE; CONTROL GROUP; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MUTATION; POLYMERASE CHAIN REACTION; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE; TUMOR VOLUME;

CASE-CONTROL STUDIES; CYCLIN D1; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PITUITARY NEOPLASMS;

EID: 35549008510     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Burrow GN, Worzman G, Rewcastle NB et al: Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N Engl J Med, 1981; 304: 156-58
2. Asa SL, Ezzat S: The Pathogenesis of pituitary tumors. Nature, 2002; 2: 836-49
3. Asa SL: Tumors of the pituitary gland. Atlas of tumor pathology. Third series, Fascicle 22 (Armed Forces Institute of Pathology. Washington D.C, 1998)
4. Betticher DC, Thatcher N, Altermatt HJ et al: Alternate splicing produces a novel cyclin D1 transcript. Oncogene, 1995; 11(5): 1005-11
5. Solomon AD, Wang Y, Fox SR et al: Cyclin D1 splice variants: Differential effects on localization, Rb Phosphorylation and cellular transformation. J Biol Chem, 2003; 278(32): 30339-47
6. Callender T, El-Naggar AK, Lee MS et al: PRAD-1 (CCND1)/Cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer, 1994; 74: 152-58
7. Matthias C, Branigan K, Jahnke V et al: Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res, 1998; 4(10): 2411-18
8. Zheng Y, Shen H, Sturgis EM et al: Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Carcinogenesis, 2001; 22(8): 1195-99
9. Park K, Han S, Kim H-Y, Ko I: Cytologic evaluation of cyclin D1 expression in primary breast carcinoma. Cancer, 2001; 93(3): 211-15
10. Wang L, Habutchi T, Mitsumori K et al: Cyclin D1 gene polymorphism is associated with increased risk of urinary bladder cancer. Carcinogenesis, 2002; 23(2): 257-64
11. Zhang YJ, Chen SY, Chen CJ, Santella RM: Polymorphism in cyclin D1 gene and hepatocellular carcinoma. Mol Carcinog, 2002; 33(2): 125-29
12. McKay JA, Douglas JJ, Ross VG et al: Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Aberdeen Colorectal Initiative. Int J Cancer, 2000; 88(1): 77-81
13. Porter TR, Richards FM, Houlston RS et al: Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) polymorphism to familial and sporadic colorectal cancer. Oncogene, 2002; 21(12): 1928-33
14. Dhar KK, Branigan K, Howells RE et al: Prognostic significance of cyclin D1 gene (CCND1) polymorphism in epithelial ovarian cancer. Int J Gynecol Cancer, 1999; 9(4): 342-47
15. Waf1/Cip1 expression is predictive of poor clinical outcome in serious epithelial ovarian cancer. Clin Cancer Res, 2004; 10: 5168-77
16. Krippl P, Langsenlehner U, Renner W et al: The 870G>A polymorphism of the cyclin D1 gene is not associated with breast cancer. Breast Cancer Res Treat, 2003; 82(3): 165-68
17. Hibberts NA, Simpson DJ, Bicknell JE et al: Analysis of Cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors. Clin Cancer Res, 1999; 5: 2133-39
18. Simpson DJ, Frost SJ, Bicknell JE et al: Aberrant expression of G1/S regulators is a frequent event in sporadic pituitary adenomas. Carcinogenesis, 2001; 22(8): 1149-54
19. Simpson DJ, Fryer AA, Grossman AB et al: Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas. Carcinogenesis, 2001; 22(11): 1801-7
20. Saeger W, Schreiber S, Ludecke DK: Cyclins D1 and D3 topoisomerase II alpha in inactive pituitary adenomas. Endocr Pathol, 2001; 12(1): 39-47
21. Jordan S, Lidhar K, Korbonits M ety al: Cyclin D and cyclin E expression in normal and adenomatous pituitary. Eur J Endocrinol, 2000; 143(1): R1-6
22. Hardy J, Vezina JL: Transsphenoidal neurosurgery of intracranial neoplasm in Advances in Neurology Thompson RA, Green JR (eds.) Raven Press New York, 1976; 261-74
23. Qian X, Kulig E, Jim L, Lloyd RV: Expression of D-Type cyclins in normal and neoplastic rat pituitary. Endocrinology, 1998; 139(4): 2058-67
24. Gazioglu E, Aydogan F, Kilic I et al: Bilateral breast cancer in a male patient with prolactinoma history. Archives of Balkan Medical Union, 2004; 39(4): 335-36